2030 年电化学生物感测器市场预测：按类型、用途和地区分類的全球分析

根据 Stratistics MRC 的数据，2023 年全球电化学生物感测器市场规模为 172.7 亿美元，预计在预测期内年复合成长率为 8.65%，到 2030 年将达到 308.7 亿美元。

电化学生物感测器是将电化学感测器与生物辨识成分（例如酵素、抗体或 DNA）结合的分析工具，用于鉴定和检测特定分析物或生物分子。它的工作原理是基于识别元件和目标分析物相互作用引起的电化学反应。这些生物感测器经常用于选择性和灵敏地检测各种物质，包括生物标记、病原体和环境污染物。

根据国际糖尿病联盟的数据，预计到 2035 年将有超过 5.9 亿人患有糖尿病，这意味着市场在整个预测期内将快速扩张。

对现场检测的需求不断增长

对现场检测的需求不断增长是电化学生物感测器市场的主要促进因素。现场护理测试提供快速、便捷的诊断解决方案，使医疗保健专业人员能够在患者床边或远端做出即时决策。电化学生物感测器由于其高灵敏度和快速结果而非常适合这些用途。促进疾病的早期发现、持续监测和及时干预，特别是在紧急情况和慢性病管理方面。人们越来越重视可及且负担得起的医疗保健，特别是在资源匮乏的地区，这正在推动电化学生物感测器在现场检测中的采用，并推动市场扩张。

成本限制

开发先进的生物感测器技术成本高昂，影响了这些设备的承受能力。高製造成本可能会阻碍广泛普及，特别是在资源有限的医疗保健环境和新兴市场。此外，对精确品管的需求增加了製造成本，这进一步限制了市场成长。

医疗保健领域的技术进步

医疗保健领域的技术进步为电化学生物感测器市场创造了巨大的机会。随着小型化、无线连接和资料分析的进步，生物感测器变得更加复杂且更容易使用。这些进步实现了即时监控、远端医疗应用以及将生物感测器整合到可穿戴设备中，以增强患者照护和疾病管理。此外，生物感测器与人工智慧和物联网等新兴技术的整合将进一步扩展其能力，并为创新诊断和监测解决方案提供机会。

有关医疗保健设备使用的法规问题

有关医疗保健设备使用的严格法规对电化学生物感测器市场构成了重大威胁。医用生物感测器的开发和商业化需要满足复杂的法规要求网络，包括卫生当局的核准。遵守这些严格的法规非常耗时、成本高昂且具有挑战性，并且可能会延迟我们产品的推出或阻止我们进入市场。此外，严格的要求也可能抑制中小企业的市场准入。

COVID-19 的影响：

COVID-19 的爆发对电化学生物感测器市场产生了积极影响。儘管对快速准确检测病毒的生物感测器的需求有所增加，但供应链和临床业务的中断带来了挑战。对即时检测解决方案的需求以及用于检测 SARS-CoV-2 抗体的生物感测器的开发推动了创新。然而，研发活动的延迟和供应链的限制影响了更广泛的市场。随着疫情消退，市场预计将復苏，重点关注感染疾病诊断以外的多种用途。

诊断领域预计将在预测期内成为最大的行业

由于对快速、准确和用户友好的诊断解决方案的需求不断增长，诊断领域预计将主导市场。诊断在生物标记、病原体和疾病相关分子的检测中提供高灵敏度和特异性。生物感测器具有从临床诊断到环境和食品安全的广泛应用，是早期疾病检测、监测和研究的宝贵工具。它为诊断和现场护理测试位置提供即时资料的能力正在推动细分市场的扩张。

预计在预测期内，即时领域的年复合成长率最高

由于对快速和分散诊断解决方案的需求不断增长，预测在预测期内，现场护理测试领域将推动市场发展。电化学生物感测器由于其便携性、快速结果和易于使用而适合 POC 应用。它使医疗保健专业人员能够在患者身边及时做出决策，为更好的疾病管理和早期检测提供即时见解。此外，POC 测试在资源有限的环境、偏远地区和紧急情况下至关重要。随着全球转向可及且负担得起的医疗保健，电化学生物感测器在 POC 环境中的采用预计将激增，从而推动市场成长。

占比最大的地区：

在预测期内，由于医疗保健支出的增加和即时检测技术的采用，北美预计将占据最大的市场。主要生物技术和製药公司的存在以及对医疗保健的大量投资正在推动该地区的技术进步和创新生物感测器应用。此外，北美完善的医疗保健系统和不断增加的老年人口正在促进市场成长，使其成为全球电化学生物感测器市场的主导者。

复合年复合成长率最高的地区：

由于医疗保健意识的提高、慢性病患病的增加以及对疾病早期检测的兴趣日益浓厚，亚太地区的电化学生物感测器市场正在显着增长。在这个人口稠密且多元化的地区，对诊断工具和医疗设备的需求正在上升。此外，政府加强医疗基础设施的配合措施和生物感测器技术的技术进步正在进一步推动市场扩张。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

• 公司简介
  • 其他市场参与者的综合分析（最多 3 家公司）
  • 主要企业SWOT分析（最多3家企业）
• 区域分割
  • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
• 竞争基准化分析
  • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

• 概述
• 利害关係人
• 调查范围
• 调查方法
  • 资料探勘
  • 资料分析
  • 资料检验
  • 研究途径
• 调查来源
  • 主要调查来源
  • 二次调查来源
  • 先决条件

第3章市场趋势分析

• 促进因素
• 抑制因素
• 机会
• 威胁
• 应用分析
• 新兴市场
• 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

• 供应商的议价能力
• 买方议价能力
• 替代的威胁
• 新进入者的威胁
• 竞争公司之间的敌对关係

第5章全球电化学生物感测器市场：按类型

• 诊断
  • DNA生物感测器
  • 葡萄糖生物感测器
  • 免疫感测器
  • 其他诊断类型
• 监视
  • 直接监控
  • 间接监测

第6章全球电化学生物感测器市场：依用途

• 医疗保健诊断
• 即时检测
• 调查
• 其他用途

第7章全球电化学生物感测器市场：按地区

• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙
  • 其他欧洲国家
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 纽西兰
  • 韩国
  • 其他亚太地区
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 卡达
  • 南非
  • 其他中东和非洲

第8章进展

• 合约、伙伴关係、协作和合资企业
• 收购和合併
• 新产品发布
• 业务扩展
• 其他关键策略

第9章公司简介

• Abbott Laboratories
• Bayer AG
• Bio-Rad Laboratories
• Biosensors International Group Ltd.
• Conductive Technologies Inc.
• I-SENS, Inc
• Medtronics
• Philips Healthcare
• Roche Holding AG
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific

According to Stratistics MRC, the Global Electrochemical Biosensors Market is accounted for $17.27 billion in 2023 and is expected to reach $30.87 billion by 2030 growing at a CAGR of 8.65% during the forecast period. Electrochemical biosensors are analytical tools that combine an electrochemical transducer with a biological recognition component (such as enzymes, antibodies, or DNA) to identify and measure particular analytes or biomolecules. Based on the electrochemical reaction caused by the interaction of the recognition element and the target analyte, they function. These biosensors are frequently used to measure a variety of substances, including biomarkers, pathogens, environmental pollutants, and more, in a selective and sensitive manner.

According to the International Diabetic Federation more than 590 million people are expected to develop diabetes by 2035, implying that the market would increase rapidly throughout the projected period.

Market Dynamics:

Driver:

Rising demand for point-of-care testing

The increased demand for point-of-care testing serves as a key driver in the electrochemical biosensor market. Point-of-care testing offers rapid and convenient diagnostic solutions, enabling healthcare professionals to make real-time decisions at the patient's bedside or in remote settings. Electrochemical biosensors, with their high sensitivity and quick results, are well-suited for these applications. They facilitate early disease detection, continuous monitoring, and timely interventions, particularly in emergency situations and for chronic disease management. The growing emphasis on accessible and affordable healthcare, especially in resource-limited areas, is propelling the adoption of electrochemical biosensors in point-of-care testing, driving market expansion.

Restraint:

Cost constraints

The development of advanced biosensor technologies can be expensive, impacting the affordability of these devices. High production costs can hinder their widespread adoption, especially in resource-limited healthcare settings and emerging markets. Additionally, the need for precise quality control adds to production costs, which further restrains market growth.

Opportunity:

Technological advancements in healthcare sector

Technological advancements in the healthcare sector present a significant opportunity in the electrochemical biosensor market. With the ongoing development of miniaturization, wireless connectivity, and data analytics, biosensors are becoming more sophisticated and user-friendly. These advancements enable real-time monitoring, telehealth applications, and the integration of biosensors into wearable devices, thus enhancing patient care and disease management. Moreover, the convergence of biosensors with emerging technologies like artificial intelligence and the Internet of Things further expands their capabilities, offering opportunities for innovative diagnostic and monitoring solutions.

Threat:

Regulatory challenges for the use of healthcare equipment

Strict regulations for the use of healthcare equipment pose a notable threat to the electrochemical biosensor market. The development and commercialization of biosensors for medical purposes involve navigating a complex web of regulatory requirements, including approvals from health authorities. Compliance with these stringent regulations is time-consuming, costly, and often challenging, potentially delaying product launches and hindering market entry. Moreover, stringent requirements may also discourage smaller players from entering the market.

COVID-19 Impact:

The COVID-19 pandemic has had a positive impact on the electrochemical biosensor market. While there was increased demand for biosensors for rapid and accurate testing of the virus, disruptions in supply chains and clinical operations created challenges. The need for point-of-care testing solutions and the development of biosensors for detecting SARS-CoV-2 antibodies drove innovation. However, the broader market was influenced by delays in research and development activities and supply chain constraints. As the pandemic recedes, the market is expected to rebound with a focus on diverse applications beyond infectious disease diagnostics.

The diagnosis segment is expected to be the largest during the forecast period

The diagnosis segment is predicted to dominate the market due to the growing demand for rapid, accurate, and user-friendly diagnostic solutions. Diagnosis offers high sensitivity and specificity in detecting biomarkers, pathogens, and disease-related molecules. With applications ranging from clinical diagnostics to environmental and food safety, biosensors are invaluable tools for early disease detection, monitoring, and research. Their ability to provide real-time data and point-of-care testing positions for diagnosis is propelling segment expansion.

The point of care testing segment is expected to have the highest CAGR during the forecast period

The point of care testing segment is poised to drive the market during the forecast period, owing to the increasing demand for rapid and decentralized diagnostic solutions. Electrochemical biosensors, with their portability, quick results, and ease of use, are well-suited for POC applications. They empower healthcare professionals to make timely decisions at the patient's side, offering real-time insights for better disease management and early detection. Moreover, POC testing is crucial in resource-limited settings, remote areas, and emergency situations. With a global shift towards accessible and affordable healthcare, the adoption of electrochemical biosensors in POC settings is expected to surge, propelling market growth.

Region with largest share:

During the forecast period, North America is anticipated to account for the largest market owing to regions rising healthcare expenditure and the adoption of point-of-care testing technologies. The presence of major biotechnology and pharmaceutical companies, along with significant investments in healthcare, promotes technological advancements and innovative biosensor applications in the region. Moreover, North America's well-established healthcare system and a growing geriatric population contribute to the market's growth, making it a prominent player in the global electrochemical biosensors market.

Region with highest CAGR:

The electrochemical biosensors market in the Asia Pacific is witnessing substantial growth due to rising healthcare awareness, increasing prevalence of chronic diseases, and a growing focus on early disease detection. With a large and diverse population, the region's demand for diagnostic tools and medical devices is on the rise. Additionally, government initiatives to enhance healthcare infrastructure and technological advancements in biosensor technologies are further driving the market's expansion.

Key players in the market:

Some of the key players in Electrochemical Biosensors market include: Abbott Laboratories, Bayer AG, Bio-Rad Laboratories, Biosensors International Group Ltd., Conductive Technologies Inc., I-SENS, Inc, Medtronics, Philips Healthcare, Roche Holding AG, Siemens Healthineers, Sysmex Corporation and Thermo Fisher Scientific.

Key Developments:

In February 2023, FREDsense Technologies Corp., the leader in field-ready water testing kits that detect chemicals in drinking and wastewater, announced that their platform can detect and measure PFAS in just hours, compared to traditional methods.

In September 2023, Abbott announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes. The transaction expands Abbott's presence in diabetes care, building on its world-leading FreeStyle Libre® portfolio of continuous glucose monitoring technology and furthering the company's efforts to develop connected solutions for making diabetes management even more personal and precise.

Types Covered:

• Diagnosis
• Monitoring

Applications Covered:

• Healthcare Diagnostics
• Point Of Care Testing
• Research Laboratories
• Other Applications

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Application Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Electrochemical Biosensors Market, By Type

• 5.1 Introduction
• 5.2 Diagnosis
  • 5.2.1 DNA Biosensors
  • 5.2.2 Glucose Biosensors
  • 5.2.3 Immunosensors
  • 5.2.4 Other Diagnosis types
• 5.3 Monitoring
  • 5.3.1 Direct Monitoring
  • 5.3.2 Indirect Monitoring

6 Global Electrochemical Biosensors Market, By Application

• 6.1 Introduction
• 6.2 Healthcare Diagnostics
• 6.3 Point Of Care Testing
• 6.4 Research Laboratories
• 6.5 Other Applications

7 Global Electrochemical Biosensors Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Abbott Laboratories
• 9.2 Bayer AG
• 9.3 Bio-Rad Laboratories
• 9.4 Biosensors International Group Ltd.
• 9.5 Conductive Technologies Inc.
• 9.6 I-SENS, Inc
• 9.7 Medtronics
• 9.8 Philips Healthcare
• 9.9 Roche Holding AG
• 9.10 Siemens Healthineers
• 9.11 Sysmex Corporation
• 9.12 Thermo Fisher Scientific

List of Tables

• Table 1 Global Electrochemical Biosensors Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 3 Global Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 4 Global Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 5 Global Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 6 Global Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 7 Global Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 8 Global Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 9 Global Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 10 Global Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 11 Global Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 12 Global Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 13 Global Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 14 Global Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 15 Global Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 16 North America Electrochemical Biosensors Market Outlook, By Country (2021-2030) ($MN)
• Table 17 North America Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 18 North America Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 19 North America Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 20 North America Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 21 North America Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 22 North America Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 23 North America Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 24 North America Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 25 North America Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 26 North America Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 27 North America Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 28 North America Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 29 North America Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 30 North America Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 31 Europe Electrochemical Biosensors Market Outlook, By Country (2021-2030) ($MN)
• Table 32 Europe Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 33 Europe Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 34 Europe Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 35 Europe Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 36 Europe Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 37 Europe Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 38 Europe Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 39 Europe Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 40 Europe Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 41 Europe Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 42 Europe Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 43 Europe Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 44 Europe Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 45 Europe Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 46 Asia Pacific Electrochemical Biosensors Market Outlook, By Country (2021-2030) ($MN)
• Table 47 Asia Pacific Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 48 Asia Pacific Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 49 Asia Pacific Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 50 Asia Pacific Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 51 Asia Pacific Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 52 Asia Pacific Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 53 Asia Pacific Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 54 Asia Pacific Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 55 Asia Pacific Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 56 Asia Pacific Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 57 Asia Pacific Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 58 Asia Pacific Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 59 Asia Pacific Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 60 Asia Pacific Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 61 South America Electrochemical Biosensors Market Outlook, By Country (2021-2030) ($MN)
• Table 62 South America Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 63 South America Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 64 South America Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 65 South America Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 66 South America Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 67 South America Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 68 South America Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 69 South America Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 70 South America Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 71 South America Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 72 South America Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 73 South America Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 74 South America Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 75 South America Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 76 Middle East & Africa Electrochemical Biosensors Market Outlook, By Country (2021-2030) ($MN)
• Table 77 Middle East & Africa Electrochemical Biosensors Market Outlook, By Type (2021-2030) ($MN)
• Table 78 Middle East & Africa Electrochemical Biosensors Market Outlook, By Diagnosis (2021-2030) ($MN)
• Table 79 Middle East & Africa Electrochemical Biosensors Market Outlook, By DNA Biosensors (2021-2030) ($MN)
• Table 80 Middle East & Africa Electrochemical Biosensors Market Outlook, By Glucose Biosensors (2021-2030) ($MN)
• Table 81 Middle East & Africa Electrochemical Biosensors Market Outlook, By Immunosensors (2021-2030) ($MN)
• Table 82 Middle East & Africa Electrochemical Biosensors Market Outlook, By Other Diagnosis types (2021-2030) ($MN)
• Table 83 Middle East & Africa Electrochemical Biosensors Market Outlook, By Monitoring (2021-2030) ($MN)
• Table 84 Middle East & Africa Electrochemical Biosensors Market Outlook, By Direct Monitoring (2021-2030) ($MN)
• Table 85 Middle East & Africa Electrochemical Biosensors Market Outlook, By Indirect Monitoring (2021-2030) ($MN)
• Table 86 Middle East & Africa Electrochemical Biosensors Market Outlook, By Application (2021-2030) ($MN)
• Table 87 Middle East & Africa Electrochemical Biosensors Market Outlook, By Healthcare Diagnostics (2021-2030) ($MN)
• Table 88 Middle East & Africa Electrochemical Biosensors Market Outlook, By Point Of Care Testing (2021-2030) ($MN)
• Table 89 Middle East & Africa Electrochemical Biosensors Market Outlook, By Research Laboratories (2021-2030) ($MN)
• Table 90 Middle East & Africa Electrochemical Biosensors Market Outlook, By Other Applications (2021-2030) ($MN)